Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Alopecia areata significantly affects emotional well-being and quality of life, especially in younger adults.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Understanding genetics is crucial for treating heart and skin diseases.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Trichoscopy helps diagnose and assess the severity of two types of hair loss diseases, androgenetic alopecia and alopecia areata.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Serum IMA levels don't help diagnose AGA but may indicate its severity.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

New treatments for acne scars are safer and more effective because we understand the causes better.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Wigs significantly improve the well-being of people with severe hair loss.

COVID-19 doesn't make alopecia areata worse.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Some people with alopecia areata, a hair loss condition, get better within a year without treatment, but it can happen again.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata patients often have low vitamin D levels, suggesting they might benefit from vitamin D supplements.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

People with skin diseases feel more stigmatized than those without.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Dupilumab helps children with alopecia areata regrow hair safely.